Last $2.30 USD
Change Today -0.02 / -0.86%
Volume 398.4K
ONTY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher S. Henney B.Sc. (Hons.), Ph.D., D.Sc.

Chairman, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee, Oncothyreon Inc
AgeTotal Calculated CompensationThis person is connected to 78 board members in 8 different organizations across 12 different industries.

See Board Relationships
73$135,000

Background*

Dr. Christopher S. Henney, also known as Chris, BSc (Hons), PhD, DSc co-founded Dendreon Corp., and served as its Executive Chairman from January 2001 to June 16, 2004, the Chief Executive Officer from May 1995 to January 2003 and as its President from December 1998 to December 2000. Dr. Henney co-founded ICOS Corp. in 1989 and served as its Executive Vice President, Chief Scientific Officer and Scientific Director from 1989 to 1995. In 1981, he Co-founded Immunex Corporation, ...

Read Full Background

Corporate Headquarters*

2601 Fourth Avenue
Seattle, Washington 98121

United States

Phone: 206-801-2100
Fax: 206-801-2101

Board Members Memberships*

Director
Former Non-Executive Director and Member of Compensation Committee
Director
1995-N/A
Former Chairman of the Board
1996-N/A
Former Director
1999-2004
Former Director
2000-N/A
Chairman, Chairman of Corporate Governance & Nominating Committee and Member of Audit Committee
2005-Present
Chairman, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee
2005-Present
Vice Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation & Organizational Development Committee
2005-N/A
Former Independent Director, Member of Audit Committee and Member of Compensation Committee
2005-Present
Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2009-2010
Former Director
2010-Present
Chairman of the Board
2012-Present
Chairman of the Board
2013-Present
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

PhD
University of Birmingham
ScD
University of Birmingham
BS
University of Birmingham

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$105,000
Total Calculated Compensation$135,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONTY:US $2.30 USD -0.02

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOTHYREON INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.